West Pharmaceutical Services, Inc. is set to announce its earnings results, potentially impacting its stock price.
Stock AI’s forecasts:
🔴 -12.0% short-term ⬇️
🟢 +1.7% long-term ⬆️
Stock AI’s (WST) Forecast get (+6.0% Profit)
StockAI’s analysis delivers real-world results. On 08 February 2024, $WST ($412.84), StockAI predicted a long-term 🔴 sell signal. It was accurate: 1 month later price dropped to $387.9 (🔴-6.0%). Selling WST on this signal yielded a +6.0% profit 💰💰.
WST-West Pharmaceutical Services, Inc. News
🔴 West Pharmaceutical Services is set to announce its earnings results before the market opens on Thursday, April 25th.
🟢 West Pharmaceutical Services posts Q1 earnings dip, but raises EPS outlook for the full year.
🔴 Mn Services Vermogensbeheer B.V. decreased its position in WST by 3.6% in the fourth quarter.
🔴 AIA Group Ltd. trimmed its holdings in WST by 15.4% during the 4th quarter.
🟢 West Pharmaceutical Services has received an average rating of “Moderate Buy” from five brokerages covering the stock.
🔴 Zacks Research dropped their Q1 2024 earnings per share estimates for West Pharmaceutical Services.
West Pharmaceutical Services, Inc. (WST) has recently seen a mix of negative and positive news impacting its stock price. While the company is set to announce its earnings results, which may have initially caused some uncertainty among investors, the positive outlook for full-year earnings has provided some reassurance. The decrease in positions by Mn Services Vermogensbeheer B.V. and AIA Group Ltd. could have contributed to a slight decline in the stock price. However, the overall rating of “Moderate Buy” and the raised EPS outlook have likely helped mitigate any significant decreases. Zacks Research’s lowered earnings estimates for Q1 2024 may have also had a slight negative impact on the stock price.
Overall, the stock of West Pharmaceutical Services, Inc. may experience some short-term fluctuations due to the mix of negative and positive news. However, the long-term forecast of a slight increase in price indicates that investors may still have confidence in the company’s future performance. As always, it is important for investors to carefully consider all available information and potential risks before making any investment decisions.
WST-West Pharmaceutical Services, Inc. Analyst Ratings
Analyst Ratings for West Pharmaceutical Services, Inc. Stock:
📈 Zacks Research analyst increased their rating on West Pharmaceutical Services, Inc. stock from Hold to Buy.
📉 MarketBeat.com analyst downgraded their rating on West Pharmaceutical Services, Inc. stock from Buy to Hold.
📈 Morningstar analyst upgraded their rating on West Pharmaceutical Services, Inc. stock from Underperform to Outperform.
Sources:
1. Zacks Research
2. MarketBeat.com
3. Morningstar
Disclaimer
Investors may consider the AI predictions and news summaries as one factor in their investment decisions alongside their own research and risk tolerance.
Ready to analyze your own portfolio?
Get the same AI-powered insights for any stock you choose. It's easy!
